Conferences
Pediatric Paracorporeal and Extracorporeal Therapies Summit (PPETS)
Tuesday, October 6 - 8, 2026 | 8:00 AM – 5:00 PM | Texas Children's Hospital
Join us for two day conference that will bring together leading experts and frontline clinicians to focus on the current landscape, indications, and challenges in pediatric extracorporeal therapies, including ECMO and CRRT.
At the conclusion of the lecture, the participants should be better able to:
Describe the current landscape, indications, and challenges in pediatric extracorporeal therapies, including ECMO and CRRT.
Apply evidence-informed and consensus-based approaches to the initiation, management, and discontinuation of extracorporeal support.
Evaluate practice variability and its impact on patient outcomes to inform more standardized care processes.
Integrate emerging technologies, data-driven tools, and simulation-based learning into clinical practice to improve performance and safety.
Implement strategies aimed at improving patient-centered outcomes, including reduction of complications and optimization of short- and long-term recovery.
Develop future avenues for research in the field of pediatric extracorporeal therapies.
Target Audience
Physicians, fellows, residents, medical students, advanced practice providers, nurses, and other healthcare providers
Accreditation
Accreditation Statement
Texas Children’s Hospital is accredited by the Texas Medical Association to provide continuing medical education for physicians.
Credit Designation
Texas Children’s Hospital designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
PLANNING COMMITTEE DISCLOSURE
The members of the Planning Committee and others involved in the planning of this activity have reported no relevant financial relationships with any ineligible companies.
Conference Support Statement
This CME activity did not receive any financial support from ineligible company.